CS
INFI

Candriam SCA’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Candriam SCA’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-80,000
Closed -$108K – 713
2016
Q4 		$108K Sell
80,000
-129,000
-62% -$168K ﹤0.01% 663
2016
Q3 		$326K Hold
209,000
– – 0.01% 626
2016
Q2 		$278K Hold
209,000
– – 0.01% 627
2016
Q1 		$1.09M Sell
209,000
-31,900
-13% -$195K 0.03% 414
2015
Q4 		$1.89M Hold
240,900
– – 0.05% 304
2015
Q3 		$2.04M Sell
240,900
-24,100
-9% -$222K 0.05% 339
2015
Q2 		$2.9M Hold
265,000
– – 0.06% 321
2015
Q1 		$3.71M Buy
265,000
+30,000
+13% +$459K 0.07% 304
2014
Q4 		$3.97M Buy
+235,000
New +$3.42M 0.08% 271

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Candriam SCA's INFI Position: Q1 2017 in Review

Candriam SCA sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2017, closing a stake of 80,000 shares — an estimated $108K sold.

Candriam SCA first reported a position in INFI in Q4 2014 and held it in 9 quarters. The position peaked at $3.97M in Q4 2014. 80 funds tracked by Wall St. Rank hold INFI as of Q1 2017.

  • Candriam SCA reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Candriam SCA sold 80,000 Infinity Pharmaceuticals, Inc. shares in Q1 2017, an estimated $108K.
  • Candriam SCA first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2014 and held it in 9 quarters.
  • Candriam SCA's Infinity Pharmaceuticals, Inc. position peaked at $3.97M in Q4 2014.
  • 80 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2017.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.